Business Context and Reporting Period
This Form 8-K was filed by Oragenics, Inc. on January 22, 2004. The report serves as a current notification regarding a specific corporate event rather than a periodic financial statement.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a listing event and does not contain financial performance data.
Material Changes
The primary material change reported is the acceptance of Oragenics, Inc. common shares for quotation on the OTC Bulletin Board under the stock symbol "OGEN".
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The report is limited to the disclosure required under Regulation FD regarding the stock listing.
Investor Verification Checklist
- Verify the trading status of the stock symbol "OGEN" on the OTC Bulletin Board.
- Review the attached Press Release (Exhibit 99.1) for additional context on the listing.
- Consult the company's most recent 10-K or 10-Q filings for actual financial performance metrics, as they are absent from this 8-K.